Health

#2026-285Decree No. 2026-285 of April 16, 2026, on the Contribution of Insured Persons to the Costs Related to Medications with Low Medical Service and Their Beneficiaries' Rights from Work Accidents or Occupational Diseases

🇫🇷France··Other·Medium Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

This decree mandates that insured individuals in France will now have to share the costs of certain medications that are considered to offer low medical service. It deletes the provision that previously extended this cost-sharing obligation to the beneficiaries' rights from workplace accidents or occupational diseases.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • Insured persons must now contribute to the costs of low medical service drugs.
  • The obligation for beneficiaries' rights from work accidents or occupational diseases to share these costs is removed.

Obligations

What this law requires

high

Insured individuals must participate in the cost of medications providing low medical benefit as specified in the decree.

insured individuals
operational
high

Insured individuals must share the costs associated with medications classified as having low medical service.

insured individuals
operational
medium

The provision extending cost-sharing obligations to beneficiaries of workplace accidents or occupational diseases has been removed.

healthcare providersinsurers
prohibition
high

Dependents of individuals receiving benefits due to work-related accidents or illnesses must comply with the new participation rules for medications.

dependents of beneficiaries
operational
critical

The implementation of these cost-sharing obligations will begin on October 1, 2026.

healthcare providersinsurers
October 1, 2026
operational

Affected Parties

Insured individualsBeneficiaries of work accident or occupational disease pensions

Tags

healthcare,insurance,pharmaceuticals